Dotinurad is a pharmaceutical active ingredient under investigation for its role as a selective urate reabsorption inhibitor. It has been studied in clinical trials for conditions related to hyperuricemia.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1285572-51-1
Ospemifene
pharmaceutical raw material
4-amino-2,3,5,6-tetradeuterio-N-(6-methoxypyrimidin-4-yl)benzenesulfonamide
pharmaceutical raw material
Tigulixostat
pharmaceutical raw material
Mycophenolate mofetil
pharmaceutical raw material
(3,5-dichloro-4-hydroxyphenyl)-(1,1-dioxo-2H-1,3-benzothiazol-3-yl)methanone
VOFLAIHEELWYGO-UHFFFAOYSA-N
C1N(C2=CC=CC=C2S1(=O)=O)C(=O)C3=CC(=C(C(=C3)Cl)O)Cl